| 标题 |
1115P NRG GY012: A randomized phase II study comparing single-agent cediranib with olaparib/durvalumab, cediranib/durvalumab, and olaparib/capivasertib in women with recurrent, persistent or metastatic endometrial cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:B. Rimmel; D. Bender; D. Enserro; S. Westin; M.A. Powell; et al 出版日期:2025-09-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)